{"id":11977,"date":"2026-05-08T06:46:38","date_gmt":"2026-05-08T13:46:38","guid":{"rendered":"https:\/\/cellpeptides.com\/?p=11977"},"modified":"2026-05-28T07:12:41","modified_gmt":"2026-05-28T14:12:41","slug":"slu-pp-332-explained-benefits-common-dosages-use-cases","status":"publish","type":"post","link":"https:\/\/cellpeptides.com\/hr\/knowledgebase\/slu-pp-332-explained-benefits-common-dosages-use-cases\/","title":{"rendered":"SLU-PP-332 Obja\u0161njeno: Prednosti, uobi\u010dajene doze i na\u010dini primjene"},"content":{"rendered":"\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<figure class=\"wp-block-image size-full is-resized\"><img decoding=\"async\" width=\"600\" height=\"700\" src=\"https:\/\/cellpeptides.com\/wp-content\/uploads\/2026\/04\/slu-pp-332-overview-featured-image-2.png\" alt=\"slu-pp-332-overview-featured-image\" class=\"wp-image-11982\" style=\"width:422px;height:auto\"\/><\/figure>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<p class=\"wp-block-paragraph\">Plenty of compounds\/peptides build muscle by boosting natural growth hormone. SLU-PP-332 does something quite different. Like most synthetic compounds, it has a direct natural analogue, but it\u2019s one you\u2019ll never see coming if you haven\u2019t heard of SLU-PP-332 (<a href=\"https:\/\/cellpeptides.com\/product\/buy-slu-pp-322-5mg\/\" target=\"_blank\" rel=\"noreferrer noopener\">you can buy SLU-PP-332 here<\/a>) before.<em> Exercise.<\/em><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">SLU-PP-332 triggers the same kinds of metabolic changes you\u2019d usually only see in elite endurance athletes. [<a href=\"#footnote_1_11977\" id=\"identifier_1_11977\" class=\"footnote-link footnote-identifier-link\" title=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37739806\/\">1<\/a>] The rodent studies that proved the concept are some of the most interesting papers you\u2019ll ever read \u2014 \u201ccouch potato\u201d mice treated with SLU-PP-332 suddenly had the endurance of \u201ccolleagues\u201d that researchers had actively subjected to training. All without any changes to their diets or workout regimens. (You can just picture them running 70 percent longer and 40 percent further than before on tiny treadmills, can\u2019t you?)<\/p>\n<\/div>\n<\/div>\n\n\n\n<p class=\"wp-block-paragraph\">The research potential absolutely isn\u2019t limited to turning sedentary mice into little roadrunners. When SLU-PP-332 gets to work \u2014 by activating so-called estrogen-related receptors, chemical switches for better energy metabolism \u2014 it builds instant stamina, boosts fat oxidation, increases mitochondrial density, and pushes muscle fiber composition toward the more fatigue-resistant type.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Some people call SLU-PP-332 \u201cexercise in a bottle,\u201d and that\u2019s fair. It\u2019s obvious why athletes would be interested in an instant stamina builder, but there\u2019s real medical potential, too. The most obvious application? People who <em>can\u2019t<\/em> move \u2014 because they\u2019re stuck in hospital with IV drips and other machinery attached to them \u2014 lose muscle shockingly fast. SLU-PP-332 might just change that.<\/p>\n\n\n\n<h2 class=\"wp-block-heading has-text-align-center\">A Very Brief History of SLU-PP-332<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Some peptides and similar compounds get discovered quite accidentally, while some research team or another is looking into something completely different. That wasn\u2019t the case with SLU-PP-332. The researchers who created it were very intentional about its design. They wanted to make a compound that targeted estrogen-related receptors, orphan compounds that look a bit like estrogen receptors but are activated by a different, still unknown compound, and they had the goal of developing a new treatment for metabolic disease.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Lots of mystery still surrounds ERRs, but when Dr Thomas Burris and his team got to work on SLU-PP-332, they already knew that ERRs:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Make new mitochondria<\/li>\n\n\n\n<li>Encourage the body to burn fat for energy<\/li>\n\n\n\n<li>Balance cell energy expenditure overall<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Unable to find the natural \u201cactivation button,\u201d they made one from scratch. That compound is SLU-PP-332 \u2014 and so far, studies in mice have proven that it effectively induces weight loss and improves insulin resistance. That\u2019s exciting on its own, but there\u2019s more, of course. By far the most interesting property of SLU-PP-332 is its ability to push muscles into fatigue-resistant mode \u2014 to build the kind of slow-twitch oxidative muscle fibers you\u2019d usually only see in marathon runners. Except the mice in the studies hadn\u2019t even so much as trained for a 5 K.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">This compound deserves some shameless repetition, so here that is again. SLU-PP-332 is an instant stamina compound in a world full of people who either don\u2019t exercise or actually can\u2019t. For that reason alone, you\u2019ll be seeing it around \u2014 because researchers eager to push new discoveries simply can\u2019t leave it alone.<\/p>\n\n\n\n<h2 class=\"wp-block-heading has-text-align-center\">How Does SLU-PP-332 Work?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">So, SLU-PP-332 builds endurance in the most sedentary specimens \u2014 but how?<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">SLU-PP-332 hijacks the estrogen-related receptors that work as genetic switches within cells, ERRs \u03b1, \u03b3, and \u03b4. Once inside cells, it starts a whole cascade of gene expression, and SLU-PP-332 basically orders cells to reprogram themselves to become super efficient.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Three main things then happen:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Cells make more mitochondria (you\u2019ve heard it before \u2014 \u201cthe power house of the cell\u201d and all that) \u2014 and cells\u2019 total energy capacity goes up.<\/li>\n\n\n\n<li>Cells also get told to pick fat, instead of glucose, as their preferred power source. That\u2019s simultaneously more efficient and more fat-burning.<\/li>\n\n\n\n<li>We already said ERRs rewrite genetic programs, and this part is pretty exciting, too. SLU-PP-332 tells slow-twitch muscle fiber genes to express themselves more. Slow-twitch, also called Type 1, fibers are full of capillaries and mitochondria, and extremely resistant to fatigue. You\u2019ll see them in elite athletes who spend most of their days either training or optimizing their training regimes.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Not a performance enhancer, then (those wear off), but a genetic switch. SLU-PP-332 permanently changes cell behavior \u2014 from standard to high-efficiency and optimized for endurance.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Exercise does exactly the same thing, by the way. (No, not the \u201cI sign up for the gym in January and get back to the couch in February\u201d kind, but the \u201cserious athlete\u201d kind.) Except with SLU-PP-332, working out is optional. That\u2019s what makes it so important.<\/p>\n\n\n\n<h2 class=\"wp-block-heading has-text-align-center\">What Applications Has SLU-PP-332 Research Looked at So Far (and What Could Be Next)?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Studies point to the use cases that investigators in the fitness and biohacking communities are most interested in \u2014 SLU-PP-332 can \u201ctransform fitness and help people lose weight by boosting metabolic pathways and aerobic exercise\u201d as well as opening the door to \u201ctherapeutic advantages for metabolic syndrome and its associated disease.\u201d [<a href=\"#footnote_2_11977\" id=\"identifier_2_11977\" class=\"footnote-link footnote-identifier-link\" title=\"https:\/\/www.researchgate.net\/profile\/Bhupendra-Mahale\/publication\/385096831_Unlocking_the_potential_slu-pp-332_and_the_future_of_exercise_Enhancement_and_Metabolic_health\/links\/67163cba24a01038d0fa3ea3\/Unlocking-the-potential-SLU-PP-332-and-the-future-of-exercise-Enhancement-and-Metabolic-health.pdf\">2<\/a>]\n\n\n\n<p class=\"wp-block-paragraph\">Let\u2019s not lie; that\u2019s where the current focus is. Researchers haven\u2019t neglected to dip their toes into deeper waters either, however, because the ERRs SLU-PP-332 activates have potential uses in any area where mitochondrial function and energy production have become impaired.<\/p>\n\n\n\n<h3 class=\"wp-block-heading has-text-align-left\">SLU-PP-332, Exercise Mimetics and Metabolic Health<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">We\u2019ve already told you all about the impact SLU-PP-332 has on endurance \u2014 mice treated with the compound can run 70 percent longer, even when they were the mouse equivalent of an office worker doing nothing but sitting at a desk all day. That first study, which proved that the concept worked, has been followed by others [<a href=\"file:\/\/\/C:\/Users\/IngridaU\/Downloads\/<a href=\"#footnote_3_11977\" id=\"identifier_3_11977\" class=\"footnote-link footnote-identifier-link\" title=\"https:\/pubs.acs.org\/doi\/abs\/10.1021\/acschembio.2c00720&quot;&gt;((https:\/\/pubs.acs.org\/doi\/abs\/10.1021\/acschembio.2c00720\">3<\/a>], and SLU-PP-332 has received widespread coverage in the press [<a href=\"#footnote_4_11977\" id=\"identifier_4_11977\" class=\"footnote-link footnote-identifier-link\" title=\"https:\/\/www.medicalnewstoday.com\/articles\/new-drug-may-help-lose-weight-reduce-fat-by-mimicking-exercise\">4<\/a>] for precisely that reason.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Exercise activates a beneficial state that was, until now, impossible to synthetically replicate. SLU-PP-332 has permanently changed that \u2014 and there\u2019s no question that researchers will continue to study the best ways to use it to boost stamina in the groups of people who need that kind of support the most.<\/p>\n\n\n\n<h3 class=\"wp-block-heading has-text-align-left\">SLU-PP-332 Applications in Heart Failure and Cardiovascular Health Research<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">A failing heart works very differently than a healthy one \u2014 instead of running on fatty acid oxidation, it shifts to glucose. Very inefficient. Could SLU-PP-332 reprogram that, through its positive impact on muscle structure and mitochondrial building? Research that tries to answer this question is already under way. So far, the conclusion is that SLU-PP-332 \u201csignificantly improved ejection fraction, ameliorated fibrosis, and increased survival.\u201d<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Good news, but just the beginning. One day, as the researchers behind that study said, SLU-PP-332 could become a \u201cnovel class of heart failure treatment.\u201d [<a href=\"#footnote_5_11977\" id=\"identifier_5_11977\" class=\"footnote-link footnote-identifier-link\" title=\"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/CIRCULATIONAHA.123.066542\">5<\/a>]\n\n\n\n<h3 class=\"wp-block-heading has-text-align-left\">What About Sarcopenia and Age-Related Muscle Wasting?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">That\u2019s exactly the most obvious use case for SLU-PP-332 \u2014 and we\u2019re thrilled to be following the latest developments in this area. One new study, freshly published in 2025, divided women undergoing hip arthroplasty for coxarthrosis into active and sedentary groups. They both had samples taken during surgery. Experiments followed, and the samples treated with SLU-PP-332 showed less cytotoxicity and cell death, less oxidative stress, and higher Glutathione levels. [<a href=\"#footnote_6_11977\" id=\"identifier_6_11977\" class=\"footnote-link footnote-identifier-link\" title=\"https:\/\/www.frontiersin.org\/journals\/physiology\/articles\/10.3389\/fphys.2025.1616693\/full\">6<\/a>]\n\n\n\n<p class=\"wp-block-paragraph\">We\u2019re still a long way off, but the potential is already clear. SLU-PP-332 might well be able to help older people, who naturally lose muscle, hold onto stronger, healthier, muscles. At a basic level, that would give many the opportunity to live independently for longer. The dream, though, is the kind of thing you rarely see now. Being able to run marathons in your 70s.<\/p>\n\n\n\n<h2 class=\"wp-block-heading has-text-align-center\">SLU-PP-332 in Metabolic Disease Research (and Beyond)<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Going back to its original purpose, SLU-PP332 has also shown promise in the fields of obesity management and its secondary complications \u2014 type 2 diabetes, insulin sensitivity, and more. A 2024 study called SLU-PP-332 an \u201ceffective agent for weight loss.\u201d It also, however, noted an indirect positive impact on kidney health. [<a href=\"#footnote_7_11977\" id=\"identifier_7_11977\" class=\"footnote-link footnote-identifier-link\" title=\"https:\/\/jrenendo.com\/Article\/jre-25143\">7<\/a>]\n\n\n\n<p class=\"wp-block-paragraph\">Then, there\u2019s this \u2014 still early days, but very much worth following. One study found that SLU-PP-332 inhibits tumor growth in prostate cancer by targeting ERRs. [<a href=\"#footnote_8_11977\" id=\"identifier_8_11977\" class=\"footnote-link footnote-identifier-link\" title=\"https:\/\/pubs.acs.org\/doi\/abs\/10.1021\/acschembio.0c00670\">8<\/a>] Other research has investigated the very real possibility that SLU-PP-332 could be developed as a COVID treatment, with a special focus on cases of long COVID \u2014 where the symptoms become chronic as patients\u2019 quality of life dwindles.<\/p>\n\n\n\n<h2 class=\"wp-block-heading has-text-align-center\">How Is SLU-PP-332 Administered in Research Settings?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Researchers in the middle of preclinical research choose their route of administration with the goal of achieving two things \u2014 consistent delivery (keeps study outcomes reproducible) and systemic delivery (to fully observe the effects). [<a href=\"#footnote_9_11977\" id=\"identifier_9_11977\" class=\"footnote-link footnote-identifier-link\" title=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0306987724001051\">9<\/a>]\n\n\n\n<p class=\"wp-block-paragraph\">That\u2019s why intraperitoneal injection has become the most common delivery method for SLU-PP-332. IP injection makes efficient absorption possible in rodent studies. The \u201cvehicle solution\u201d is different than it is for most peptides. SLU-PP-332 is often reconstituted with a mix of DMSO, PEG, and saline. It doesn\u2019t do well with bacteriostatic water, and researchers who try that immediately notice that the mixture gets cloudy or has floating particles.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Research into different delivery methods is also underway. Oral dosing is not unheard of, and sublingual SLU-PP-332 also exists, but it would completely change the bioavailability of the compound. For now, IP injection is the go-to.<\/p>\n\n\n\n<h2 class=\"wp-block-heading has-text-align-center\">How Are SLU-PP-332 Dosing Protocols Calculated?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">A consensus doesn\u2019t yet exist around SLU-PP-332 dosing \u2014 any new research protocols are usually based on the animal studies already published in peer-reviewed journals. Those are preclinical studies, and no established human dose exists yet.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The most-quoted study, which showed that sedentary mice given SLU-PP-332 could suddenly run for impressive periods of time, used a dose of 10 mg per kilogram of body weight (mg\/kg), given via intraperitoneal injection once a day.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Anecdotal reports from biohackers and longevity researchers are also interesting. Many strongly recommend a starting dose of 50 micrograms.<\/strong> That low starting point allows for acclimatization and lets investigators see what the initial results are. After that, researchers with the general goal of building endurance, boosting energy, and muscle preservation report going up to 100 micrograms.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Higher doses are also cited. Common dosing protocols you will see mentioned in various studies include:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>A protocol of 200 to 300 micrograms over two daily doses \u2014 for endurance<\/li>\n\n\n\n<li>400 micrograms daily to achieve systemic effects, including for weight loss studies<\/li>\n\n\n\n<li>Even doses of 500 micrograms are sometimes reported, especially among biohackers<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Dosing is frequent because of the half life of SLU-PP-332 \u2014 it clears from the system after around six hours. Reports of cycling SLU-PP-332 for two weeks and then taking a break of a week or two are not uncommon and has the goal of preventing tolerance.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">These preliminary reports can be very interesting to people investigating the compound, but designing studies always comes back to the established literature.<\/p>\n\n\n\n<h2 class=\"wp-block-heading has-text-align-center\">FAQs<\/h2>\n\n\n\n<div class=\"schema-faq wp-block-yoast-faq-block\"><div class=\"schema-faq-section\" id=\"faq-question-1777400327546\"><strong class=\"schema-faq-question\"><strong>What is SLU-PP-332 used for?<\/strong><\/strong> <p class=\"schema-faq-answer\">n lab settings, researchers mainly research SLU-PP-332 as an exercise mimetic (that is, a compound that makes your body act like you\u2019ve exercised, but without actually working out) and a future treatment for metabolic disease.<br\/><br\/>Things researchers are interested in are varied \u2014 if SLU-PP-332 can facilitate a switch from burning glucose to burning fat, how it can help preserve muscle and build stamina, to what extent it can fight age-related symptoms, and even if SLU-PP-332 can serve as a new heart failure treatment.\u00a0 Reports also indicate that SLU-PP-332 boosts energy.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1777400350333\"><strong class=\"schema-faq-question\"><strong>What are the side effects of SLU-PP-332?<\/strong><\/strong> <p class=\"schema-faq-answer\">The studies done so far have shown a favorable side effect profile. In other words, not many are reported. The mice that showed such amazing endurance didn\u2019t have their diets changed, on the other hand, and starting vigorous exercise without increasing calories can reasonably be expected to lead to fatigue and weight loss beyond the stated goal.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1777400368500\"><strong class=\"schema-faq-question\"><strong>How is SLU-PP-332 different from other peptides?<\/strong><\/strong> <p class=\"schema-faq-answer\">To start with (and don\u2019t kick yourself, because this is a common question), SLU-PP-332 isn\u2019t even a peptide at all. It\u2019s a small compound that was engineered to fight metabolic disease. Its mechanism of action is also completely different.<br\/><br\/>GHS peptides trigger the release of more natural growth hormone, something that leads to faster recovery and easier muscle building. Metabolic peptides (OAD9604, Tesamorelin, etc) induce fat loss. SLU-PP-332 is more of a genetic regulator, and its observed effects amount to metabolic reprogramming for better endurance and smarter energy use.<\/p> <\/div> <\/div>\n\n\n\n<h3 class=\"wp-block-heading\"><em>Scientific References and Sources<\/em><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n<ol class=\"footnotes\"><li id=\"footnote_1_11977\" class=\"footnote\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37739806\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/37739806\/<\/a><span class=\"footnote-back-link-wrapper\">[<a href=\"#identifier_1_11977\" class=\"footnote-link footnote-back-link\">\u21a9<\/a>]<\/span><\/li><li id=\"footnote_2_11977\" class=\"footnote\"><a href=\"https:\/\/www.researchgate.net\/profile\/Bhupendra-Mahale\/publication\/385096831_Unlocking_the_potential_slu-pp-332_and_the_future_of_exercise_Enhancement_and_Metabolic_health\/links\/67163cba24a01038d0fa3ea3\/Unlocking-the-potential-SLU-PP-332-and-the-future-of-exercise-Enhancement-and-Metabolic-health.pdf\">https:\/\/www.researchgate.net\/profile\/Bhupendra-Mahale\/publication\/385096831_Unlocking_the_potential_slu-pp-332_and_the_future_of_exercise_Enhancement_and_Metabolic_health\/links\/67163cba24a01038d0fa3ea3\/Unlocking-the-potential-SLU-PP-332-and-the-future-of-exercise-Enhancement-and-Metabolic-health.pdf<\/a><span class=\"footnote-back-link-wrapper\">[<a href=\"#identifier_2_11977\" class=\"footnote-link footnote-back-link\">\u21a9<\/a>]<\/span><\/li><li id=\"footnote_3_11977\" class=\"footnote\">https:\/pubs.acs.org\/doi\/abs\/10.1021\/acschembio.2c00720\">((https:\/\/pubs.acs.org\/doi\/abs\/10.1021\/acschembio.2c00720<\/a><span class=\"footnote-back-link-wrapper\">[<a href=\"#identifier_3_11977\" class=\"footnote-link footnote-back-link\">\u21a9<\/a>]<\/span><\/li><li id=\"footnote_4_11977\" class=\"footnote\"><a href=\"https:\/\/www.medicalnewstoday.com\/articles\/new-drug-may-help-lose-weight-reduce-fat-by-mimicking-exercise\">https:\/\/www.medicalnewstoday.com\/articles\/new-drug-may-help-lose-weight-reduce-fat-by-mimicking-exercise<\/a><span class=\"footnote-back-link-wrapper\">[<a href=\"#identifier_4_11977\" class=\"footnote-link footnote-back-link\">\u21a9<\/a>]<\/span><\/li><li id=\"footnote_5_11977\" class=\"footnote\"><a href=\"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/CIRCULATIONAHA.123.066542\">https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/CIRCULATIONAHA.123.066542<\/a><span class=\"footnote-back-link-wrapper\">[<a href=\"#identifier_5_11977\" class=\"footnote-link footnote-back-link\">\u21a9<\/a>]<\/span><\/li><li id=\"footnote_6_11977\" class=\"footnote\"><a href=\"https:\/\/www.frontiersin.org\/journals\/physiology\/articles\/10.3389\/fphys.2025.1616693\/full\">https:\/\/www.frontiersin.org\/journals\/physiology\/articles\/10.3389\/fphys.2025.1616693\/full<\/a><span class=\"footnote-back-link-wrapper\">[<a href=\"#identifier_6_11977\" class=\"footnote-link footnote-back-link\">\u21a9<\/a>]<\/span><\/li><li id=\"footnote_7_11977\" class=\"footnote\"><a href=\"https:\/\/jrenendo.com\/Article\/jre-25143\">https:\/\/jrenendo.com\/Article\/jre-25143<\/a><span class=\"footnote-back-link-wrapper\">[<a href=\"#identifier_7_11977\" class=\"footnote-link footnote-back-link\">\u21a9<\/a>]<\/span><\/li><li id=\"footnote_8_11977\" class=\"footnote\"><a href=\"https:\/\/pubs.acs.org\/doi\/abs\/10.1021\/acschembio.0c00670\">https:\/\/pubs.acs.org\/doi\/abs\/10.1021\/acschembio.0c00670<\/a><span class=\"footnote-back-link-wrapper\">[<a href=\"#identifier_8_11977\" class=\"footnote-link footnote-back-link\">\u21a9<\/a>]<\/span><\/li><li id=\"footnote_9_11977\" class=\"footnote\"><a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0306987724001051\">https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0306987724001051<\/a><span class=\"footnote-back-link-wrapper\">[<a href=\"#identifier_9_11977\" class=\"footnote-link footnote-back-link\">\u21a9<\/a>]<\/span><\/li><\/ol>","protected":false},"excerpt":{"rendered":"<p>Mnogi spojevi\/peptidi grade mi\u0161i\u0107e poticanjem prirodnog hormona rasta. SLU-PP-332 \u010dini ne\u0161to sasvim drugo. Poput ve\u0107ine sintetskih spojeva, ima izravan prirodni analog,<\/p>","protected":false},"author":701,"featured_media":11980,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"ub_ctt_via":"","footnotes":""},"categories":[80,83,85,82],"tags":[],"kb_topic":[118,119,123,128],"class_list":["post-11977","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-peptides-for-bodybuilding","category-peptides-for-fat-burning","category-peptides-for-longevity","category-weight-loss-research"],"featured_image_src":"https:\/\/cellpeptides.com\/wp-content\/uploads\/2026\/04\/slu-pp-332-overview-featured-image.png","author_info":{"display_name":"Avantika Mann (Ph.D.)","author_link":"https:\/\/cellpeptides.com\/hr\/knowledgebase\/author\/avantika\/"},"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>SLU-PP-332 Explained: Benefits, Common Dosages &amp; Use Cases - CellPeptides<\/title>\n<meta name=\"description\" content=\"Complete SLU-PP-332 5mg guide - ERR \u03b1\/\u03b2\/\u03b3 agonist, exercise-mimetic mechanism, dosing protocols and endurance research uses.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cellpeptides.com\/hr\/baza-znanja\/slu-pp-332-explained-benefits-common-dosages-use-cases\/\" \/>\n<meta property=\"og:locale\" content=\"hr_HR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SLU-PP-332 Explained: Benefits, Common Dosages &amp; Use Cases - CellPeptides\" \/>\n<meta property=\"og:description\" content=\"Complete SLU-PP-332 5mg guide - ERR \u03b1\/\u03b2\/\u03b3 agonist, exercise-mimetic mechanism, dosing protocols and endurance research uses.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cellpeptides.com\/hr\/baza-znanja\/slu-pp-332-explained-benefits-common-dosages-use-cases\/\" \/>\n<meta property=\"og:site_name\" content=\"CellPeptides\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-08T13:46:38+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-28T14:12:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cellpeptides.com\/wp-content\/uploads\/2026\/04\/slu-pp-332-overview-featured-image.png\" \/>\n\t<meta property=\"og:image:width\" content=\"600\" \/>\n\t<meta property=\"og:image:height\" content=\"700\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Avantika Mann (Ph.D.)\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Napisao\/la\" \/>\n\t<meta name=\"twitter:data1\" content=\"Avantika Mann (Ph.D.)\" \/>\n\t<meta name=\"twitter:label2\" content=\"Procijenjeno vrijeme \u010ditanja\" \/>\n\t<meta name=\"twitter:data2\" content=\"10 minuta\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cellpeptides.com\/knowledgebase\/slu-pp-332-explained-benefits-common-dosages-use-cases\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/cellpeptides.com\/knowledgebase\/slu-pp-332-explained-benefits-common-dosages-use-cases\/\"},\"author\":{\"name\":\"Avantika Mann (Ph.D.)\",\"@id\":\"https:\/\/cellpeptides.com\/#\/schema\/person\/ad0609bf2e9da4910eb0de2cf3b1c6f5\"},\"headline\":\"SLU-PP-332 Explained: Benefits, Common Dosages &amp; Use Cases\",\"datePublished\":\"2026-05-08T13:46:38+00:00\",\"dateModified\":\"2026-05-28T14:12:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cellpeptides.com\/knowledgebase\/slu-pp-332-explained-benefits-common-dosages-use-cases\/\"},\"wordCount\":2108,\"publisher\":{\"@id\":\"https:\/\/cellpeptides.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/cellpeptides.com\/knowledgebase\/slu-pp-332-explained-benefits-common-dosages-use-cases\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cellpeptides.com\/wp-content\/uploads\/2026\/04\/slu-pp-332-overview-featured-image.png\",\"articleSection\":[\"Body\/muscle building Research\",\"In-vitro Fat Burning Research\",\"Longevity Research\",\"Weight Loss Research\"],\"inLanguage\":\"hr\"},{\"@type\":[\"WebPage\",\"FAQPage\"],\"@id\":\"https:\/\/cellpeptides.com\/knowledgebase\/slu-pp-332-explained-benefits-common-dosages-use-cases\/\",\"url\":\"https:\/\/cellpeptides.com\/knowledgebase\/slu-pp-332-explained-benefits-common-dosages-use-cases\/\",\"name\":\"SLU-PP-332 Explained: Benefits, Common Dosages &amp; Use Cases - CellPeptides\",\"isPartOf\":{\"@id\":\"https:\/\/cellpeptides.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cellpeptides.com\/knowledgebase\/slu-pp-332-explained-benefits-common-dosages-use-cases\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cellpeptides.com\/knowledgebase\/slu-pp-332-explained-benefits-common-dosages-use-cases\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cellpeptides.com\/wp-content\/uploads\/2026\/04\/slu-pp-332-overview-featured-image.png\",\"datePublished\":\"2026-05-08T13:46:38+00:00\",\"dateModified\":\"2026-05-28T14:12:41+00:00\",\"description\":\"Complete SLU-PP-332 5mg guide - ERR \u03b1\/\u03b2\/\u03b3 agonist, exercise-mimetic mechanism, dosing protocols and endurance research uses.\",\"breadcrumb\":{\"@id\":\"https:\/\/cellpeptides.com\/knowledgebase\/slu-pp-332-explained-benefits-common-dosages-use-cases\/#breadcrumb\"},\"mainEntity\":[{\"@id\":\"https:\/\/cellpeptides.com\/knowledgebase\/slu-pp-332-explained-benefits-common-dosages-use-cases\/#faq-question-1777400327546\"},{\"@id\":\"https:\/\/cellpeptides.com\/knowledgebase\/slu-pp-332-explained-benefits-common-dosages-use-cases\/#faq-question-1777400350333\"},{\"@id\":\"https:\/\/cellpeptides.com\/knowledgebase\/slu-pp-332-explained-benefits-common-dosages-use-cases\/#faq-question-1777400368500\"}],\"inLanguage\":\"hr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cellpeptides.com\/knowledgebase\/slu-pp-332-explained-benefits-common-dosages-use-cases\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"hr\",\"@id\":\"https:\/\/cellpeptides.com\/knowledgebase\/slu-pp-332-explained-benefits-common-dosages-use-cases\/#primaryimage\",\"url\":\"https:\/\/cellpeptides.com\/wp-content\/uploads\/2026\/04\/slu-pp-332-overview-featured-image.png\",\"contentUrl\":\"https:\/\/cellpeptides.com\/wp-content\/uploads\/2026\/04\/slu-pp-332-overview-featured-image.png\",\"width\":600,\"height\":700,\"caption\":\"slu-pp-332-overview-featured-image\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cellpeptides.com\/knowledgebase\/slu-pp-332-explained-benefits-common-dosages-use-cases\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cellpeptides.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SLU-PP-332 Explained: Benefits, Common Dosages &amp; Use Cases\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cellpeptides.com\/#website\",\"url\":\"https:\/\/cellpeptides.com\/\",\"name\":\"CellPeptides\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/cellpeptides.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cellpeptides.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"hr\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cellpeptides.com\/#organization\",\"name\":\"CellPeptides\",\"url\":\"https:\/\/cellpeptides.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"hr\",\"@id\":\"https:\/\/cellpeptides.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cellpeptides.com\/wp-content\/uploads\/2025\/02\/CellPeptides-logo2-lc2.png\",\"contentUrl\":\"https:\/\/cellpeptides.com\/wp-content\/uploads\/2025\/02\/CellPeptides-logo2-lc2.png\",\"width\":697,\"height\":152,\"caption\":\"CellPeptides\"},\"image\":{\"@id\":\"https:\/\/cellpeptides.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/cellpeptides.com\/#\/schema\/person\/ad0609bf2e9da4910eb0de2cf3b1c6f5\",\"name\":\"Avantika Mann (Ph.D.)\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"hr\",\"@id\":\"https:\/\/cellpeptides.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/cellpeptides.com\/wp-content\/uploads\/2026\/04\/Avantika-Mann-writer-96x96.jpg\",\"contentUrl\":\"https:\/\/cellpeptides.com\/wp-content\/uploads\/2026\/04\/Avantika-Mann-writer-96x96.jpg\",\"caption\":\"Avantika Mann (Ph.D.)\"},\"url\":\"https:\/\/cellpeptides.com\/hr\/knowledgebase\/author\/avantika\/\"},{\"@type\":\"Question\",\"@id\":\"https:\/\/cellpeptides.com\/knowledgebase\/slu-pp-332-explained-benefits-common-dosages-use-cases\/#faq-question-1777400327546\",\"position\":1,\"url\":\"https:\/\/cellpeptides.com\/knowledgebase\/slu-pp-332-explained-benefits-common-dosages-use-cases\/#faq-question-1777400327546\",\"name\":\"What is SLU-PP-332 used for?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"n lab settings, researchers mainly research SLU-PP-332 as an exercise mimetic (that is, a compound that makes your body act like you\u2019ve exercised, but without actually working out) and a future treatment for metabolic disease.<br\/><br\/>Things researchers are interested in are varied \u2014 if SLU-PP-332 can facilitate a switch from burning glucose to burning fat, how it can help preserve muscle and build stamina, to what extent it can fight age-related symptoms, and even if SLU-PP-332 can serve as a new heart failure treatment.\u00a0 Reports also indicate that SLU-PP-332 boosts energy.\",\"inLanguage\":\"hr\"},\"inLanguage\":\"hr\"},{\"@type\":\"Question\",\"@id\":\"https:\/\/cellpeptides.com\/knowledgebase\/slu-pp-332-explained-benefits-common-dosages-use-cases\/#faq-question-1777400350333\",\"position\":2,\"url\":\"https:\/\/cellpeptides.com\/knowledgebase\/slu-pp-332-explained-benefits-common-dosages-use-cases\/#faq-question-1777400350333\",\"name\":\"What are the side effects of SLU-PP-332?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The studies done so far have shown a favorable side effect profile. In other words, not many are reported. The mice that showed such amazing endurance didn\u2019t have their diets changed, on the other hand, and starting vigorous exercise without increasing calories can reasonably be expected to lead to fatigue and weight loss beyond the stated goal.\",\"inLanguage\":\"hr\"},\"inLanguage\":\"hr\"},{\"@type\":\"Question\",\"@id\":\"https:\/\/cellpeptides.com\/knowledgebase\/slu-pp-332-explained-benefits-common-dosages-use-cases\/#faq-question-1777400368500\",\"position\":3,\"url\":\"https:\/\/cellpeptides.com\/knowledgebase\/slu-pp-332-explained-benefits-common-dosages-use-cases\/#faq-question-1777400368500\",\"name\":\"How is SLU-PP-332 different from other peptides?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"To start with (and don\u2019t kick yourself, because this is a common question), SLU-PP-332 isn\u2019t even a peptide at all. It\u2019s a small compound that was engineered to fight metabolic disease. Its mechanism of action is also completely different.<br\/><br\/>GHS peptides trigger the release of more natural growth hormone, something that leads to faster recovery and easier muscle building. Metabolic peptides (OAD9604, Tesamorelin, etc) induce fat loss. SLU-PP-332 is more of a genetic regulator, and its observed effects amount to metabolic reprogramming for better endurance and smarter energy use.\",\"inLanguage\":\"hr\"},\"inLanguage\":\"hr\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SLU-PP-332 Obja\u0161njeno: Prednosti, uobi\u010dajene doze i slu\u010dajevi upotrebe - CellPeptides","description":"Potpuni vodi\u010d za SLU-PP-332 5mg - ERR \u03b1\/\u03b2\/\u03b3 agonist, mehanizam opona\u0161anja vje\u017ebanja, protokoli doziranja i istra\u017eiva\u010dke primjene za izdr\u017eljivost.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cellpeptides.com\/hr\/baza-znanja\/slu-pp-332-explained-benefits-common-dosages-use-cases\/","og_locale":"hr_HR","og_type":"article","og_title":"SLU-PP-332 Explained: Benefits, Common Dosages &amp; Use Cases - CellPeptides","og_description":"Complete SLU-PP-332 5mg guide - ERR \u03b1\/\u03b2\/\u03b3 agonist, exercise-mimetic mechanism, dosing protocols and endurance research uses.","og_url":"https:\/\/cellpeptides.com\/hr\/baza-znanja\/slu-pp-332-explained-benefits-common-dosages-use-cases\/","og_site_name":"CellPeptides","article_published_time":"2026-05-08T13:46:38+00:00","article_modified_time":"2026-05-28T14:12:41+00:00","og_image":[{"width":600,"height":700,"url":"https:\/\/cellpeptides.com\/wp-content\/uploads\/2026\/04\/slu-pp-332-overview-featured-image.png","type":"image\/png"}],"author":"Avantika Mann (Ph.D.)","twitter_card":"summary_large_image","twitter_misc":{"Napisao\/la":"Avantika Mann (Ph.D.)","Procijenjeno vrijeme \u010ditanja":"10 minuta"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cellpeptides.com\/knowledgebase\/slu-pp-332-explained-benefits-common-dosages-use-cases\/#article","isPartOf":{"@id":"https:\/\/cellpeptides.com\/knowledgebase\/slu-pp-332-explained-benefits-common-dosages-use-cases\/"},"author":{"name":"Avantika Mann (Ph.D.)","@id":"https:\/\/cellpeptides.com\/#\/schema\/person\/ad0609bf2e9da4910eb0de2cf3b1c6f5"},"headline":"SLU-PP-332 Explained: Benefits, Common Dosages &amp; Use Cases","datePublished":"2026-05-08T13:46:38+00:00","dateModified":"2026-05-28T14:12:41+00:00","mainEntityOfPage":{"@id":"https:\/\/cellpeptides.com\/knowledgebase\/slu-pp-332-explained-benefits-common-dosages-use-cases\/"},"wordCount":2108,"publisher":{"@id":"https:\/\/cellpeptides.com\/#organization"},"image":{"@id":"https:\/\/cellpeptides.com\/knowledgebase\/slu-pp-332-explained-benefits-common-dosages-use-cases\/#primaryimage"},"thumbnailUrl":"https:\/\/cellpeptides.com\/wp-content\/uploads\/2026\/04\/slu-pp-332-overview-featured-image.png","articleSection":["Body\/muscle building Research","In-vitro Fat Burning Research","Longevity Research","Weight Loss Research"],"inLanguage":"hr"},{"@type":["WebPage","FAQPage"],"@id":"https:\/\/cellpeptides.com\/knowledgebase\/slu-pp-332-explained-benefits-common-dosages-use-cases\/","url":"https:\/\/cellpeptides.com\/knowledgebase\/slu-pp-332-explained-benefits-common-dosages-use-cases\/","name":"SLU-PP-332 Obja\u0161njeno: Prednosti, uobi\u010dajene doze i slu\u010dajevi upotrebe - CellPeptides","isPartOf":{"@id":"https:\/\/cellpeptides.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cellpeptides.com\/knowledgebase\/slu-pp-332-explained-benefits-common-dosages-use-cases\/#primaryimage"},"image":{"@id":"https:\/\/cellpeptides.com\/knowledgebase\/slu-pp-332-explained-benefits-common-dosages-use-cases\/#primaryimage"},"thumbnailUrl":"https:\/\/cellpeptides.com\/wp-content\/uploads\/2026\/04\/slu-pp-332-overview-featured-image.png","datePublished":"2026-05-08T13:46:38+00:00","dateModified":"2026-05-28T14:12:41+00:00","description":"Potpuni vodi\u010d za SLU-PP-332 5mg - ERR \u03b1\/\u03b2\/\u03b3 agonist, mehanizam opona\u0161anja vje\u017ebanja, protokoli doziranja i istra\u017eiva\u010dke primjene za izdr\u017eljivost.","breadcrumb":{"@id":"https:\/\/cellpeptides.com\/knowledgebase\/slu-pp-332-explained-benefits-common-dosages-use-cases\/#breadcrumb"},"mainEntity":[{"@id":"https:\/\/cellpeptides.com\/knowledgebase\/slu-pp-332-explained-benefits-common-dosages-use-cases\/#faq-question-1777400327546"},{"@id":"https:\/\/cellpeptides.com\/knowledgebase\/slu-pp-332-explained-benefits-common-dosages-use-cases\/#faq-question-1777400350333"},{"@id":"https:\/\/cellpeptides.com\/knowledgebase\/slu-pp-332-explained-benefits-common-dosages-use-cases\/#faq-question-1777400368500"}],"inLanguage":"hr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cellpeptides.com\/knowledgebase\/slu-pp-332-explained-benefits-common-dosages-use-cases\/"]}]},{"@type":"ImageObject","inLanguage":"hr","@id":"https:\/\/cellpeptides.com\/knowledgebase\/slu-pp-332-explained-benefits-common-dosages-use-cases\/#primaryimage","url":"https:\/\/cellpeptides.com\/wp-content\/uploads\/2026\/04\/slu-pp-332-overview-featured-image.png","contentUrl":"https:\/\/cellpeptides.com\/wp-content\/uploads\/2026\/04\/slu-pp-332-overview-featured-image.png","width":600,"height":700,"caption":"slu-pp-332-overview-featured-image"},{"@type":"BreadcrumbList","@id":"https:\/\/cellpeptides.com\/knowledgebase\/slu-pp-332-explained-benefits-common-dosages-use-cases\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cellpeptides.com\/"},{"@type":"ListItem","position":2,"name":"SLU-PP-332 Explained: Benefits, Common Dosages &amp; Use Cases"}]},{"@type":"WebSite","@id":"https:\/\/cellpeptides.com\/#website","url":"https:\/\/cellpeptides.com\/","name":"CellPeptides","description":"","publisher":{"@id":"https:\/\/cellpeptides.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cellpeptides.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"hr"},{"@type":"Organization","@id":"https:\/\/cellpeptides.com\/#organization","name":"CellPeptides","url":"https:\/\/cellpeptides.com\/","logo":{"@type":"ImageObject","inLanguage":"hr","@id":"https:\/\/cellpeptides.com\/#\/schema\/logo\/image\/","url":"https:\/\/cellpeptides.com\/wp-content\/uploads\/2025\/02\/CellPeptides-logo2-lc2.png","contentUrl":"https:\/\/cellpeptides.com\/wp-content\/uploads\/2025\/02\/CellPeptides-logo2-lc2.png","width":697,"height":152,"caption":"CellPeptides"},"image":{"@id":"https:\/\/cellpeptides.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/cellpeptides.com\/#\/schema\/person\/ad0609bf2e9da4910eb0de2cf3b1c6f5","name":"Avantika Mann (dr. sc.)","image":{"@type":"ImageObject","inLanguage":"hr","@id":"https:\/\/cellpeptides.com\/#\/schema\/person\/image\/","url":"https:\/\/cellpeptides.com\/wp-content\/uploads\/2026\/04\/Avantika-Mann-writer-96x96.jpg","contentUrl":"https:\/\/cellpeptides.com\/wp-content\/uploads\/2026\/04\/Avantika-Mann-writer-96x96.jpg","caption":"Avantika Mann (Ph.D.)"},"url":"https:\/\/cellpeptides.com\/hr\/knowledgebase\/author\/avantika\/"},{"@type":"Question","@id":"https:\/\/cellpeptides.com\/knowledgebase\/slu-pp-332-explained-benefits-common-dosages-use-cases\/#faq-question-1777400327546","position":1,"url":"https:\/\/cellpeptides.com\/knowledgebase\/slu-pp-332-explained-benefits-common-dosages-use-cases\/#faq-question-1777400327546","name":"Za \u0161to se koristi SLU-PP-332?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"n lab settings, researchers mainly research SLU-PP-332 as an exercise mimetic (that is, a compound that makes your body act like you\u2019ve exercised, but without actually working out) and a future treatment for metabolic disease.<br\/><br\/>Things researchers are interested in are varied \u2014 if SLU-PP-332 can facilitate a switch from burning glucose to burning fat, how it can help preserve muscle and build stamina, to what extent it can fight age-related symptoms, and even if SLU-PP-332 can serve as a new heart failure treatment.\u00a0 Reports also indicate that SLU-PP-332 boosts energy.","inLanguage":"hr"},"inLanguage":"hr"},{"@type":"Question","@id":"https:\/\/cellpeptides.com\/knowledgebase\/slu-pp-332-explained-benefits-common-dosages-use-cases\/#faq-question-1777400350333","position":2,"url":"https:\/\/cellpeptides.com\/knowledgebase\/slu-pp-332-explained-benefits-common-dosages-use-cases\/#faq-question-1777400350333","name":"Koje su nuspojave lijeka SLU-PP-332?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"The studies done so far have shown a favorable side effect profile. In other words, not many are reported. The mice that showed such amazing endurance didn\u2019t have their diets changed, on the other hand, and starting vigorous exercise without increasing calories can reasonably be expected to lead to fatigue and weight loss beyond the stated goal.","inLanguage":"hr"},"inLanguage":"hr"},{"@type":"Question","@id":"https:\/\/cellpeptides.com\/knowledgebase\/slu-pp-332-explained-benefits-common-dosages-use-cases\/#faq-question-1777400368500","position":3,"url":"https:\/\/cellpeptides.com\/knowledgebase\/slu-pp-332-explained-benefits-common-dosages-use-cases\/#faq-question-1777400368500","name":"Po \u010demu se SLU-PP-332 razlikuje od drugih peptida?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"To start with (and don\u2019t kick yourself, because this is a common question), SLU-PP-332 isn\u2019t even a peptide at all. It\u2019s a small compound that was engineered to fight metabolic disease. Its mechanism of action is also completely different.<br\/><br\/>GHS peptides trigger the release of more natural growth hormone, something that leads to faster recovery and easier muscle building. Metabolic peptides (OAD9604, Tesamorelin, etc) induce fat loss. SLU-PP-332 is more of a genetic regulator, and its observed effects amount to metabolic reprogramming for better endurance and smarter energy use.","inLanguage":"hr"},"inLanguage":"hr"}]}},"_links":{"self":[{"href":"https:\/\/cellpeptides.com\/hr\/wp-json\/wp\/v2\/posts\/11977","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cellpeptides.com\/hr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cellpeptides.com\/hr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cellpeptides.com\/hr\/wp-json\/wp\/v2\/users\/701"}],"replies":[{"embeddable":true,"href":"https:\/\/cellpeptides.com\/hr\/wp-json\/wp\/v2\/comments?post=11977"}],"version-history":[{"count":0,"href":"https:\/\/cellpeptides.com\/hr\/wp-json\/wp\/v2\/posts\/11977\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cellpeptides.com\/hr\/wp-json\/wp\/v2\/media\/11980"}],"wp:attachment":[{"href":"https:\/\/cellpeptides.com\/hr\/wp-json\/wp\/v2\/media?parent=11977"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cellpeptides.com\/hr\/wp-json\/wp\/v2\/categories?post=11977"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cellpeptides.com\/hr\/wp-json\/wp\/v2\/tags?post=11977"},{"taxonomy":"kb_topic","embeddable":true,"href":"https:\/\/cellpeptides.com\/hr\/wp-json\/wp\/v2\/kb_topic?post=11977"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}